Department of Neurology

Print Friendly

Vice-Chair, Research

Helen Ellis Endowed Chair for Parkinson's Disease Research

Director, Huntington's Disease Society of America Center of Excellence at USF

Director, Parkinson Research Foundation Center of Excellence at USF

13330 USF Laurel Drive
Tampa, FL 33612

Phone: (813) 396-9478
Fax: (813) 974-7590

Juan R. Sanchez-Ramos, M.D., Ph.D.

Movement Disorders


Graduate School: PhD, Pharmacology & Physiology University of Chicago, IL
Medical School: University of Illinois College of Medicine
Residency: Michael Reese Hospital (Internal Medicine)
University of Chicago (Neurology)
Fellowship: University of Miami (Movement Disorders)


Clinical Interests:
Neurodegenerative diseases in general with focus on Huntington's Disease and Parkinson's Disease

Research Interests:
Neurodegeneration, neurotoxicology and adult stem cell biology

Board Certification(s)
American Board of Psychiatry & Neurology (Neurology)

Movement Disorders

Selected Publications

Song, S., Sava, V., Rowe, A., Li, K., Cao, C., Mori, T., and Sanchez-Ramos, J., 2011. Granulocyte-colony stimulating factor (G-CSF) enhances recovery in mouse model of Parkinson's disease. Neurosci Lett 487, 153-157.

Carroll, E., and Sanchez-Ramos, J., 2011. Hyperkinetic movement disorders associated with HIV and other viral infections. In: Handb Clin Neurol, Vol 100 pp. 323-334.

Boyd, T. D., Bennett, S. P., Mori, T., Governatori, N., Runfeldt, M., Norden, M., Padmanabhan, J., Neame, P., Wefes, I., Sanchez-Ramos, J., Arendash, G. W., and Potter, H., 2010. GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. J Alzheimers Dis 21, 507-518.

Butterfield, L. C., Cimino, C. R., Oelke, L. E., Hauser, R. A., and Sanchez-Ramos, J., 2010. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease. Neuropsychology 24, 721-730.

Sanchez-Ramos, J., Song, S., Sava, V., Catlow, B., Lin, X., Mori, T., Cao, C., and Arendash, G. W., 2009. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice. Neuroscience 163, 55-72.